BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SenzaGen
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250831
DTEND;VALUE=DATE:20250905
DTSTAMP:20250828T194641Z
CREATED:20250303T121220Z
LAST-MODIFIED:20250828T194641Z
UID:34240-1756598400-1757030399@senzagen.com
SUMMARY:WC13
DESCRIPTION:13th World Congress on Alternatives and Animal Use in the Life Sciences\n📍 Rio de Janeiro\, Brazil | 🗓 Aug 31-Sep 4\nAt this year’s conference SenzaGen and Unilever co-chair a scientific symposium\, where Dr Andy Forreryd will present how GARD® can be applied to derive a Point-of-Departure (PoD) for quantitative skin sensitization assessment. \n \nSession #79\nUsing NAMs to derive PoDs for NGRA of skin sensitizers: Towards regulatory implementation\nTime: 9:30-11:00 | Tuesday\, September 2\nVenue: Plenary Room\nTogether with speakers from Unilever\, Research Institute for Fragrance Materials (RIFM)\, and Inotiv\, this joint symposium will cover methodological innovations in New Approach Methodologies (NAMs)\, industry case studies on deriving Points of Departure (PoDs) for fragrances\, and the challenges and opportunities for regulatory acceptance. \n \n💻 Incorporating expert knowledge in the Skin Allergy Risk Assessment (SARA) Model: an integrated approach to testing and assessment (IATA) demonstrated in case studies.\nRenato Ivan de Ávila\, PhD @Unilever \n💻 The GARD®skin Dose-Response model to derive a PoD for quantitative skin sensitization assessment.\nAndy Forreryd\, PhD @SenzaGen \n💻 Predicting PoD and potency categories using New Approach Methods: Practical experience from the fragrance industry.\nIsabella Schember\, PhD @Research Institute for Fragrance Materials (RIFM) \n💻 Integrating NAMs for quantitative skin sensitization potency assessment into regulatory frameworks: experience from the work in OECD TG 497\nEmily Reinke\, PhD\, D.A.B.T @Inotiv \nPoster #167\nGARD®skin for Medical Devices: Pre-validation results for implementation in ISO 10993-10\nThe pre-validation study of GARD®skin Medical Device confirms the method is functional\, reproducible and sufficiently accurate to proceed to the validation study phase\, as defined by the ISO TS11796.
URL:https://senzagen.com/event/wc13/
LOCATION:Rio de Janeiro\, Brazil
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2025/03/WC13-Logo-white-background.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250914
DTEND;VALUE=DATE:20250918
DTSTAMP:20250909T111839Z
CREATED:20250317T151319Z
LAST-MODIFIED:20250909T111839Z
UID:34391-1757808000-1758153599@senzagen.com
SUMMARY:Eurotox 2025
DESCRIPTION:Eurotox 2025\n Athens\, Greece |  Sep 14-17\nBooth #A24\nAdvancing NAMs for Skin Sensitization Testing\nCome meet us at this year’s Eurotox and take part in our scientific activities\, featuring an industry-hosted session\, poster presentations\, and the latest insights on GARD®. Discover how the method provides high performance\, broad applicability\, and quantitative potency information for skin sensitization testing. \nWant to connect with our scientific team while you’re there? \n \nIndustry-Hosted Session\nRegulatory update: GARD®skin in OECD TG 497\nTime: 12:00-13:00 | Tuesday\, September 16\nVenue: N. Skalkotas Hall\n \nJoin us for an interactive scientific session featuring regulatory updates\, case studies\, and a live Q&A. Key highlights: \n\nRegulatory update: GARD®skin included in OECD TG 497.\nCase studies: UVCBs\, Natural Extracts\, Formulations\, Hydrophobic Substances\, and more.\nScientific collaborations: dōTERRA\, BIC\, and Urgo.\n\nLearn how GARD®skin fits into TG 497 and what this means in practice for your regulatory testing strategy. \nPosters\nSpotlight on Essential oils\, Safe dose levels\, Hypoallergenic claims and more\n🎫 P32-09 #644 | Joint poster with DōTERRA\nComparative analysis of skin sensitization thresholds for essential oils: human\, murine\, and GARDskin Dose-Response \n🎫 P32-12 #731 | Joint poster with BIC Skin Creative\nIn vitro skin sensitization potency assessment using GARDskin Dose-Response: a case study on natural extracts-based skin-binding dyes and dye precursors \n🎫 P32-16 #923 | Joint poster with Urgo\nSupporting industry decision-making and hypoallergenicity claims using an experimental setup combining GARDskin Medical Device and Dose-Response protocols \n🎫 P23-04 #314 | ToxHub poster\nDeriving gender-sensitive Occupational Exposure Limits: Case studies on benperidol and dimethylacetamide \nMore at our booth\nExpert guidance for your regulatory challenges\nMeet ToxHub\, our consultancy unit specializing in toxicological risk assessment and regulatory strategy consulting\, with expertise across medical devices\, pharmaceuticals\, cosmetics and chemicals. \nDiscover how ToxHub can support your needs
URL:https://senzagen.com/event/eurotox-2025/
LOCATION:Athens\, Greece
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2025/03/2025-eurotox-banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20250929T100000
DTEND;TZID=Europe/Stockholm:20250929T190000
DTSTAMP:20250828T194205Z
CREATED:20250828T131114Z
LAST-MODIFIED:20250828T194205Z
UID:35415-1759140000-1759172400@senzagen.com
SUMMARY:RIFM INFOX 2025
DESCRIPTION:RIFM 2025 Information Exchange (INFOX®) Paris\nFrance Advancing Fragrance Safety Through Innovation\, Science\, and Collaboration\nDate: September 29\, 2025\nLocation: Le Méridien Etoile\, 81 Bd Gouvion-Saint-Cyr\, 75017 Paris\, France\nCome meet SenzaGen’ skin sensitization experts Dr Andy Forreryd and Dr Tim Lindberg at this year’s Research Institute for Fragrance Materials (RIFM) INFOX© meeting in Paris! \nThis exclusive event brings together leading scientists to present the latest advancements in fragrance safety science\, spanning human health and environmental protection. INFOX 2025 is a key forum for shaping the future of safe and sustainable fragrance use\, and we look forward to engaging in the discussions. \nWant to connect with our scientific team while you are in Paris?
URL:https://senzagen.com/event/rifm-infox-2025/
LOCATION:Paris\, France
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2025/08/INFOX-GENERAL-HEADER-1024x535-1-e1756387095780.png
END:VEVENT
END:VCALENDAR